Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

305
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
305
Allergic Reactions02:06

Allergic Reactions

27.5K
Overview
27.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

411
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
411
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

EAACI Guidelines on Environmental Science for Allergy and Asthma-Evidence-Based Recommendations for Prevention and Public Health Action to Mitigate the Impact of Pollen Exposure on Respiratory Allergy.

Allergy·2026
Same author

Polystyrene nanoplastics induce mitochondrial dysfunction and stress responses in human PBMCs.

Ecotoxicology and environmental safety·2026
Same author

Trace Elements in Allergy: Narrative Review.

Allergy·2026
Same author

Imbalance of type I and II interferon pathways is associated with pain perception in Sjogren's disease: a real-life study.

Frontiers in immunology·2026
Same author

Meta-Analysis on the Harm of Systemic Glucocorticosteroids in Inflammatory Upper Airway Disease and Asthma: An EAACI Task Force.

Allergy·2026
Same author

Asthma endotypes and theratypes.

Chinese medical journal pulmonary and critical care medicine·2026

相关实验视频

Updated: Jul 9, 2025

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.2K

过敏原免疫疗法治疗喘

Jasper H Kappen1, Ioana Agache2, Marek Jutel3

  • 1Department of Pulmonology, STZ Centre of Excellence for Asthma, COPD and Respiratory Allergy, Franciscus & Vlietland, Rotterdam, The Netherlands; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, National Heart and Lung Institute, Imperial College London, London, United Kingdom.

The journal of allergy and clinical immunology. In practice
|November 28, 2023
PubMed
概括

过敏原免疫疗法有效治疗IgE介导过敏和过敏性鼻炎. 新出现的证据支持其在改善喘控制中的作用,这导致其被认为是轻度/中度喘的补充疗法.

关键词:
过敏 过敏是一种过敏.临床 临床 临床 临床免疫治疗是一种免疫疗法.斯基特斯基特斯基特斯基特斯基特斯在SLIT中,您可以使用SLIT.治疗方法 治疗方法

更多相关视频

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
06:34

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma

Published on: June 4, 2017

10.0K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.4K

相关实验视频

Last Updated: Jul 9, 2025

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.2K
A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
06:34

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma

Published on: June 4, 2017

10.0K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.4K

科学领域:

  • 免疫学 免疫学 免疫学
  • 过敏研究 研究过敏
  • 呼吸系统医学 呼吸系统医学

背景情况:

  • 过敏原免疫疗法 (AIT) 是一种疾病修饰治疗IgE介导过敏的方法.
  • 它有效地减少了过敏性鼻炎患者的疾病负担和症状,无论是否患有喘.
  • 国际指导方针现在承认AIT作为轻度/中度过敏喘的附加疗法.

研究的目的:

  • 审查当前关于过敏性喘过敏原免疫治疗的证据.
  • 突出AIT在实现喘控制中的作用.
  • 讨论喘中AIT生物标志物开发的进展和局限性.

主要方法:

  • 对过敏性喘中的过敏原免疫治疗研究的文献综述.
  • 分析国际指导方针和专家建议.
  • 对患者选择和疗效的生物标志物进行当前研究的评估.

主要成果:

  • 过敏原免疫疗法显示出促进喘控制的潜力.
  • 国际机构承认AIT作为轻度/中度喘的补充治疗.
  • 生物标志物的有希望的发展已经存在,但需要进一步的数据.

结论:

  • 过敏原免疫疗法是过敏性喘的一个有价值的治疗选择.
  • 需要进一步的研究来优化患者选择,并使用生物标志物评估疗效.
  • 继续调查AIT在呼吸系统疾病中的作用是有必要的.